Belgium - Renin-Angiotensin System Medicine Use
Since 2014, Belgium Renin-Angiotensin System Medicine Use increased 0.2% year on year. In 2019, the country was number 18 among other countries in Renin-Angiotensin System Medicine Use with 152.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Belgium is overtaken by Norway, which was number 17 at 158.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Netherlands with 147.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 0.6% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile was the worst growing country at -3.5% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 152.50 |
| 2018 | 148.80 |
| 2017 | 149.10 |
| 2016 | 151.60 |
| 2015 | 151.20 |
How does Belgium rank in Renin-Angiotensin System Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
| 2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
| 17 |
#17
Norway
|
159 | 2019 | +5.0 % | +2.0 % | View data | |
| 18 |
#18
Belgium
|
153 | 2019 | +2.5 % | +0.2 % | View data | |
| 19 |
#19
Netherlands
|
147 | 2019 | +2.1 % | +0.4 % | View data | |